Clinical Trial Update: Diagnostic Utility of SGLT1/2 Inhibition to Facilitate Myocardial Glucose Suppression

View source ↗

Summary

The document describes a clinical trial evaluating whether inhibiting SGLT1/2 can improve myocardial glucose suppression for diagnostic purposes in patients wit…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cardiac Sarcoidosis

Snippet

Sponsor: University of Pennsylvania | Conditions: Cardiac Sarcoidosis | Status: RECRUITING